Skip to main content
XIAMEN COMFORT SCIENCE&TECHNOLOGY GROUP CO.,LTD. logo

XIAMEN COMFORT SCIENCE&TECHNOLOGY GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 002614 ISIN · CNE100001740 LEI · 836800FDZ2AGPPGN0875 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,711 across all filing types
Latest filing 2024-08-29 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002614

About XIAMEN COMFORT SCIENCE&TECHNOLOGY GROUP CO.,LTD.

https://www.easepal.com.cn

Xiamen Comfort Science & Technology Group Co., Ltd. specializes in the research, development, manufacturing, and global distribution of health and wellness products. The company focuses on smart healthcare solutions, primarily producing high-end massage chairs, massage appliances, and environmental health products such as air purifiers. Operating under several international brands including Ogawa, Cozzia, and Medisana, the group integrates advanced technology with ergonomic design to provide therapeutic and relaxation equipment. Its core activities encompass the entire value chain, from technological innovation and product design to large-scale manufacturing and international retail. The company emphasizes the application of intelligent sensing and automated control systems in its product lines to enhance user wellness and physical recovery.

Recent filings

Filing Released Lang Actions
半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 95% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the first half of 2024. It includes specific financial data such as beginning balances, cumulative amounts, interest, repayments, and ending balances for various related parties and subsidiaries. The presence of detailed financial figures and accounting subjects indicates this is a financial report rather than a brief announcement or certification. The document covers a half-year period (January to June 2024), which aligns with an interim or quarterly report. There is no indication that this is an announcement of a report or a certification letter, so it should not be classified as RPA or RNS. The content is too detailed and specific to be an earnings release or a financial supplement. Therefore, the most appropriate classification is an Interim / Quarterly Report (IR). The document length is under 5,000 characters but contains substantive financial data, so it qualifies as an IR report rather than an announcement. H1 2024
2024-08-29 Chinese
关于计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 奥佳华智能健康科技集团股份有限公司 regarding the provision for asset impairment as of June 30, 2024. It details the reasons, amounts, accounting basis, and impact of the impairment provision. The document is relatively short (1745 characters) and is a formal disclosure of a specific accounting event rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is also not a certification or a regulatory compliance filing. The content fits best with a Regulatory Filing (RNS) as it is a regulatory announcement about an accounting provision without being a full report or audit report.
2024-08-29 Chinese
半年报董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a board meeting resolution announcement from 奥佳华智能健康科技集团股份有限公司, detailing the approval of the 2024 half-year (semi-annual) report and related financial matters such as asset impairment provisions. It references the 2024 half-year report and a special report on the use of raised funds, but does not contain the full financial statements or detailed financial data itself. The document length is short (1212 characters) and it states that the full reports are available on designated disclosure media and websites. This matches the characteristics of a Regulatory Filing (RNS) rather than the actual Interim/Quarterly Report (IR), which would contain substantive financial data. Therefore, the correct classification is Regulatory Filings (RNS).
2024-08-29 Chinese
2024年半年度报告
Interim / Quarterly Report Classification · 98% confidence The document is titled '2024 年半年度报告' which translates to '2024 Semi-Annual Report' and contains detailed financial data, management discussion and analysis, company overview, business segments, financial metrics, and operational highlights for the first half of 2024. It includes comprehensive financial statements and analysis, typical of an Interim / Quarterly Report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. There is no indication that this is an announcement of a report publication or a certification document. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-29 Chinese
2024年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2024 Half-Year Special Report on the Deposit and Use of Raised Funds" by 奥佳华智能健康科技集团股份有限公司. It details the status of funds raised through convertible bonds, their usage, storage, and management as of June 30, 2024. The content includes specific financial figures related to fundraising, usage, and balances, as well as compliance with regulatory requirements. The document is a specialized report focusing on the use of raised capital rather than a general financial report or earnings release. It is not an announcement of a report but the report itself, containing substantive financial data and analysis about fundraising and capital usage. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2024-08-29 Chinese
关于公司股东部分股权质押公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a company's controlling shareholder. It details the number of shares pledged, the proportion of total shares, the pledgee, and the purpose of the pledge. There is no financial statement, earnings data, or management discussion. The document is short (1720 characters) and focuses on a specific shareholder transaction related to share pledging. This fits the category of a Regulatory Filing (RNS) as it is a regulatory disclosure about share pledge status and does not fit into other more specific categories like capital changes or director dealings since it is about pledged shares by a controlling shareholder, not a direct share transaction or capital change announcement.
2024-08-02 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.